According to a study by Wang et al., in vitro experiments showed that ASPP1 hypermethylation at the promoter region suppressed the ASPP1 expression, while the latter was restored after treatment of RCC cells with decitabine [34]. This evidence concerns the gene PPP1R13B and renal cell adenocarcinoma.